CVS testing breakout resistance
CVS Health Corp (CVS) presently testing breakout resistance, able to contain weekly buying pressures. From here (CVS) can fall back to recent lows, eliciting losses of 15% over the following 1-2 months. A settlement below a near-term channel bottom would accelerate this potential selloff. Inversely, if a settlement above breakout resistance occurs, this would place (CVS) in a a buy signal where gains of 15% would be expected within 2-3 months, and 20% over the following 3-5 months.
Anthony Speciale, founder of Speciale Analysis offers an affordable approach for all traders to grow into their highest potential.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.